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Background: Performance measures (PM) can be defined in STEMI and NSTE-ACS patients for the in-hospital phase. The rate of use of PM and 
their impact on clinical outcome needs to be documented.
Methods: PM were defined for STEMI and NSTE-ACS by expert consensus for assessment at admission, in-hospital treatment and time delays. 
These PM were applied to 19205 patients (7655 STEMI and 11550 NSTE-ACS) included in the Euro Heart Survey-ACS Registry. The rate of use and 
the impact of these PM on in-hospital survival was tested by univariate and multivariate analysis.
Results: Among the 19205 patients included, 865(4.5%) died during hospital stay. PM could be applied in most patients. The rate of use was 
significantly different between STEMI and NSTEMI-ACS and between survivors and non survivors. Most PM were univariate predictors of in-hospital 
survival. Adjusted for age, STEMI and Killip class, the early assessment of troponin and LVEF, use of aspirin, clopidogrel ACEI/ARB and parenteral 
anticoagulation during acute phase were predictors of in hospital mortality.
Conclusions: In-hospital PM, as defined for the EHS-ACS, can be applied in STEMI and NSTEMI-ACS and are related to in-hospital mortality.
